title: Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy.
abstract: Mutations in myelin genes cause inherited peripheral neuropathies that range in severity from adult-onset Charcot-Marie-Tooth disease type 1 to childhood-onset Dejerine-Sottas neuropathy and congenital hypomyelinating neuropathy. Many myelin gene mutants that cause severe disease, such as those in the myelin protein zero gene (MPZ) and the peripheral myelin protein 22 gene (PMP22), appear to make aberrant proteins that accumulate primarily within the endoplasmic reticulum (ER), resulting in Schwann cell death by apoptosis and, subsequently, peripheral neuropathy. We previously showed that curcumin supplementation could abrogate ER retention and aggregation-induced apoptosis associated with neuropathy-causing MPZ mutants. We now show reduced apoptosis after curcumin treatment of cells in tissue culture that express PMP22 mutants. Furthermore, we demonstrate that oral administration of curcumin partially mitigates the severe neuropathy phenotype of the Trembler-J mouse model in a dose-dependent manner. Administration of curcumin significantly decreases the percentage of apoptotic Schwann cells and results in increased number and size of myelinated axons in sciatic nerves, leading to improved motor performance. Our findings indicate that curcumin treatment is sufficient to relieve the toxic effect of mutant aggregation-induced apoptosis and improves the neuropathologic phenotype in an animal model of human neuropathy, suggesting a potential therapeutic role in selected forms of inherited peripheral neuropathies.
authors: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
authors: Mehrdad
authors: M
authors: Khajavi
authors: Kensuke
authors: K
authors: Shiga
authors: Wojciech
authors: W
authors: Wiszniewski
authors: Feng
authors: F
authors: He
authors: Chad A
authors: CA
authors: Shaw
authors: Jiong
authors: J
authors: Yan
authors: Theodore G
authors: TG
authors: Wensel
authors: G Jackson
authors: GJ
authors: Snipes
authors: James R
authors: JR
authors: Lupski
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D003474:Curcumin / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006367:HeLa Cells; D015417:Hereditary Sensory and Motor Neuropathy / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans; D051379:Mice; D008817:Mice, Mutant Strains; D009185:Myelin Proteins / Q000235:genetics*; D012583:Schwann Cells / Q000187:drug effects*; D012584:Sciatic Nerve / Q000187:drug effects / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D009185:Myelin Proteins; C073687:PMP22 protein, human; D003474:Curcumin
references: Hum Mol Genet. 2000 Jul 22;9(12):1865-71
references: 10915775
references: Curr Opin Neurobiol. 2000 Oct;10(5):552-7
references: 11084316
references: Annu Rev Neurosci. 2000;23:89-125
references: 10845060
references: J Cell Biol. 1998 Feb 23;140(4):925-34
references: 9472043
references: J Cell Biol. 1992 Apr;117(1):225-38
references: 1556154
references: Nat Med. 2004 Apr;10(4):396-401
references: 15034573
references: J Neurosci. 1997 Jun 1;17(11):4190-200
references: 9151736
references: J Neurocytol. 1988 Feb;17(1):55-62
references: 3418356
references: Ann N Y Acad Sci. 1999 Sep 14;883:143-51
references: 10586240
references: Neurobiol Dis. 2006 Apr;22(1):153-64
references: 16326107
references: Clin Genet. 1974;6(2):98-118
references: 4430158
references: Nat Rev Neurosci. 2005 Jan;6(1):11-22
references: 15611723
references: Cell. 1991 Jul 26;66(2):219-32
references: 1677316
references: J Neurosci Res. 2005 Sep 15;81(6):857-64
references: 16041800
references: Science. 2004 Apr 23;304(5670):600-2
references: 15105504
references: Hum Mol Genet. 2004 Nov 1;13(21):2581-94
references: 15367490
references: J Biol Chem. 1993 May 15;268(14):10372-9
references: 8486695
references: Neurobiol Dis. 1999 Feb;6(1):1-14
references: 10078969
references: Neurogenetics. 2005 Feb;6(1):1-16
references: 15627202
references: FASEB J. 2004 Oct;18(13):1553-5
references: 15319364
references: Am J Hum Genet. 2005 Nov;77(5):841-50
references: 16252242
references: Nat Med. 2003 Dec;9(12):1533-7
references: 14608378
references: Cell. 1993 Jan 15;72(1):143-51
references: 8422677
references: J Anat. 1997 Oct;191 ( Pt 3):321-36
references: 9418989
references: J Biol Chem. 2004 Sep 24;279(39):40629-33
references: 15280357
references: Neurobiol Dis. 2000 Dec;7(6 Pt B):561-73
references: 11114256
references: J Neuropathol Exp Neurol. 1996 Mar;55(3):290-9
references: 8786387
references: Nat Genet. 1992 Dec;2(4):288-91
references: 1303281
references: FEBS Lett. 2002 Sep 25;528(1-3):17-22
references: 12297272
references: Neuromolecular Med. 2006;8(1-2):1-2
references: 16775363
references: Muscle Nerve. 1997 Jan;20(1):97-9
references: 8995589
references: Proc Natl Acad Sci U S A. 1992 May 15;89(10):4382-6
references: 1374899
references: Anticancer Res. 2001 Jul-Aug;21(4B):2895-900
references: 11712783
references: Brain. 2001 Nov;124(Pt 11):2177-87
references: 11673320
references: J Neurosci Res. 1996 May 15;44(4):328-37
references: 8739151
references: Hum Mol Genet. 1994 Feb;3(2):223-8
references: 8004087
references: Nat Genet. 1992 Apr;1(1):29-33
references: 1301995
references: Ann N Y Acad Sci. 1999 Sep 14;883:91-108
references: 10586235
references: Mutat Res. 2004 Nov 2;555(1-2):53-64
references: 15476851
references: J Biol Chem. 2005 Feb 18;280(7):5892-901
references: 15590663
references: Neuromuscul Disord. 1991;1(2):93-7
references: 1822787
references: Biochem Mol Biol Int. 1996 Feb;38(2):393-99
references: 8850535
references: Nature. 1992 Mar 19;356(6366):241-4
references: 1552943
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9852-7
references: 12119418